[Translation] Group A and C meningococcal polysaccharide conjugate vaccine: (1) Immunogenicity, immune persistence, and safety of 1 and 2 doses in children aged 12-23 months; (2) Immunogenicity, immune persistence, and safety of 1 dose of booster vaccination at 18 months of age for children who have completed 2 doses of primary immunization at 6-11 months of age.
评价罗益(无锡)生物制药有限公司生产的A群C群脑膜炎球菌多糖结合疫苗:(1)在12-23月龄幼儿中接种1针次和2针次的免疫原性、免疫持久性和安全性;(2)6-11月龄时完成本产品2针次基础免疫的幼儿在18月龄时加强免疫接种1针次的免疫原性、免疫持久性及其安全性。
[Translation] To evaluate the group A and group C meningococcal polysaccharide conjugate vaccine produced by Luoyi (Wuxi) Biopharmaceutical Co., Ltd.: (1) The immunogenicity, immune persistence, and safety of 1 and 2 doses of this product in children aged 12-23 months; (2) The immunogenicity, immune persistence, and safety of 1 dose of this product at 18 months of age after completing 2 doses of this product as a primary immunization.